Comparison of single photon emission computed tomography findings in cases of healthy adults and solvent-exposed adults

American Journal of Industrial Medicine

Volumn 31, Issue 1, 1997, Pages 4-14

  Fincher, Cynthia E ^a   Chang, Te Sheng ^a   Harrell, Ernest H ^a   Kettelhut, Michael C ^b   Rea, William J ^c   Johnson, Alfred ^c   Hickey, David C ^d   Simon, Theodore R ^d,e  

^a UNIVERSITY OF NORTH TEXAS   (United States)

^b ALCON RESEARCH LTD   (United States)

^c Environmental Health Center   (United States)

^d Adv Metabolic Imaging/North Dallas   (United States)

^e NONE   (United States)

Author keywords

cerebral blood flow; mixed organic solvent; neurotoxicity; nuclear medicine; single photon emission computed tomography; solvent exposure; solvent syndrome; toxicity

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; ORGANIC SOLVENT; TRACER;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; HUMAN; MALE; NEUROTOXICITY; OCCUPATIONAL EXPOSURE; QUESTIONNAIRE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BRAIN; CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; REFERENCE VALUES; SOLVENTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031026391     PISSN: 02713586     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0274(199701)31:1<4::AID-AJIM2>3.0.CO;2-1     Document Type: Article

References (42)

1. Abdul-Dayem H, Sadek S, Kouris K, Bahar R, Higazi I, Eriksson S, Englesson S, Berntman L, Sigurdsson G, Foad M, Olivecrona H (1987): Changes in cerebral perfusion after acute head injury: Comparison of CT with Tc-99m HM-PAO SPECT. Radiology 165:221-226.
2. Andersen A (1989): 99mTc-D, L-Hexamethylene-propyleneamine Oxime (99mTc-HMPAO): Basic kinetic studies of a tracer of cerebral blood flow. Cerebrovasc Brain Metab Rev 1:288-318.
3. Andersen A, Friber H, Schmidt J, Hasselbalch S (1988): Quantitative measurements of cerebral blood flow using SPECT and [99mTc-d, 1-HM-PAO compared to Xenon-133. J Cereb Blood Flow Metab 8(suppl):69-81.
4. Ariel R, Golden C, Berg R, Quaife M, Kirksen J, Forsell T, Wilson J, Graber B (1983): Regional cerebral blood flow in schizophrenics: Tests using the xenon Xe 133 inhalation method. Arch Gen Psychiatry 40:258-263.
5. Berman K, Weinberger D, Shelton R, Zee R (1987): A relationship between anatomical and physiological brain pathology in schizophrenia: lateral cerebral ventricular size predicts cortical blood flow. Am J Psychiatry 144:1277-1282.
6. Berstad J, Flekkoy K, Pedersen O (1989): Encephalopathy and polyneuropathy induced by organic solvents. J Oslo City Hosp 39:81-86.
7. Bondy S (1995): Minireview: The relation of oxidative stress and hyperexcitation to neurological disease. Proc Soc Exp Biol Med 208:337-345.
8. Callender T, Morrow L, Subramanian K, Duhon D, Ristovv M (1993): Three-dimensional brain metabolic imaging in patients with toxic encephalopathy. Environ Res 60:295-319.
9. Cesaro P, Mann M, Moretti J, Defer G, Roualdes B, Nguyen J, Degos J (1991): Central pain and thalamic hyperactivity: A single photon emission computerized tomographic study. Pain 47:329-336.
10. Costa D, Ell P, Burns A, Philpot M, Levy R (1988): CBF tomograms with [99mTc-HM-PAO in patients with dementia (Alzheimer type and HIV) and Parkinson's disease - initial results. J Cereb Blood Flow Metab 8(suppl):Sl-S7.
11. Denays R, Tondeur M, Toppet V, Ham H, Piepsz A, Spehl M, Rubinstein M, Noel P (1990): Cerebral palsy: Initial experience with Tc-99m HMPAO SPECT of the brain. Radioogy 175:111-116.
12. Dick RB (1988): Short duration exposures to organic solvents: The relationship between neurobehavioral test results and other indicators. Neurotoxicol Teratol 10:39-50.
13. Edling C, Ekberg K, Ahlborg G, Alexandersson R, Barregard L, Ekenvall L, Nilsson LSvensson (1990): Long-term follow up of workers exposed to solvents. Br J Ind Med 47:75-82.
14. Fidler A, Baker E, Letz R (1987): Neurobehavioural effects of occupational exposure to organic solvents among construction painters. Br J Ind Med 44:292-308.
15. Franzen Gingvar D (1975): Abnormal distribution of cerebral activity in chronic schizophrenia. J Psychiatric Res 12:199-214.
16. 2PET. J Nucl Med 31:1595-1600.
17. Gemmell H, Sharp P, Besson J, Crawford J, Ebmeier K, Davidson J, Smith F (1987): Differential diagnosis in dementia using the cerebral blood flow agent 99mTc HM-PAO: a SPECT study. J Comp Assist Tomogr 11:398-402.
18. Gyntelberg F, Vesterhauge S, Fog P, Isager H, Zillstorff K (1986): Acquired intolerance of organic solvents and results of vestibular testing. Am J Ind Med 9:363-370.
19. Hanninen H (1988): The psychological performance profile in occupational intoxications. Neurotoxicol Teratol 10:485-488.
20. Holman B, Carvalho P, Mendelson J, Teoh S, Nardin R, Hallgring E, Hebben N, Johnson K (1991): Brain perfusion is abnormal in cocainedependent polydrug users: A study using Technetium-99m-HMPAO and ASPECT. J Nucl Med 32:1206-1210.
21. Johnson B (1987) "Prevention of Neurotoxic Illness in Working Populations." New York: John Wiley & Sons.
22. Johnson K, Kijewski M, Becker J, Garada B, Satlin A, Holman B (1993): Quantitative brain SPECT in Alzheimer's disease and normal aging. J Nucl Med 34:2044-2048.
23. LaFrance N, Pearlson G, Schaerf F (1988): 1-123 IMP-SPECT in HIV-related dementia. Adv Funct Neuroimaging 1:9-15.
24. Lassen N, Andersen A, Friberg L, Paulson O (1988): The retention of [99mTc]-d, 1-HM-PAO in the human brain after intracarotid bolus injection: A kinetic analysis. J Cereb Blood Flow Metab 8(suppl):S13-S22.
25. Lequin M, Blok D, Pauwels E (1991): Radiopharmaceuticals for functional brain imaging with SPECT. In Freeman LM (ed): "Nuclear Medicine Annual Meeting, 1991." New York: Raven Press.
26. Lindelof B, Almkvist O, Gothe C (1992): Sleep disturbances and exposure to organic solvents. Arch Environ Health 47:104-106.
27. Masdeu J, Yudd A, Van Heertum R, Grundman M, Hriso E, O'Connell R, Luck D, Camli U, King L (1991): Single photon emission computed tomography in human immunodeficiency virus encephalopathy: A preliminary report. J Nucl Med 32:1471-1475.
28. Mathew R, Meyer J, Francis D, Semcnuk K, Mortel K, Claghorn JL (1980): Cerebral blood flow in depression. Am J Psychiatry 137:1449-1450.
29. Milanovic L, Spilich G, Vucinic G, Knezevic S, Ribaric B, Mubrin S (1990): Effects of occupational exposure to organic solvents upon cognitive performance. Neurotoxicol Teratol 12:657-660.
30. Monstad P, Nissen T, Sulg I, Mellgran S (1987): Sleep apnea and organic solvent exposure. J Neurol 234:152-154.
31. Morrow L, Ryan C, Hodgson M, Robin N (1990): Alterations in cognitive and psychological functioning after organic solvent exposure. J Occup Med 32:444-450.
32. + channels. Brain Res 526:147-152.
33. Ng T, Ong S, Lam W, Jones G (1990): Neurobehavioral effects of industrial mixed solvent exposure in Chinese printing and paint workers. Neurotoxicol Teratol 12:661-664.
34. Olsen E Seedorff L (1990): Exposure to organic solvents. II. An exposure epidemiology study. Ann Occup Hyg 34:379-389.
35. Perani D, DiPiero V, Vallar G, Cappa S, Messa C, Bottini G, Berti A, Passafiume D, Scarlato G, Gerundini P, Lenzi G, Fazio F (1988): Technetium-99m-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med 29:1507-1514.
36. Roberts L (1991): A call to action on the human brain project. Science 252:1974.
37. Ryding E, Rosen I, Elmqvist D, Ingvar D (1988): SPECT Measurements with 99mTc-HM-PAO in focal epilepsy. J Cereb Blood Flow Metab 8(suppl):S95-S100.
38. Shen W, Lee B, Park H, Siddiqui A, Wellman H, Worth R, Markand O (1990): HIPDM-SPECT Brain Imaging in the presurgical evaluation of patients with intractable seizures. J Nucl Med 31:1280-1284.
39. Stephenson G. (1990): SPECT and PET herald "decade of the brain." Diagn Imaging 12:112-125.
40. Takeuchi Y, (1988): Visual disorders due to organic solvent poisoning. Sangyo Igaku 30:236-247.
41. Testa H, Snowden J, Neary D, Shields R, Burjan W, Prescott M, Northen B, Goulding P. (1988): The use of [99mTc]-HM-PAO in the diagnosis of primary degenerative dementia. J Cereb Blood Flow Metab 8(suppl): S123-S126.
42. Tumeh S, Nagel J, English R, Moore M, Holman B (1990): Cerebral abnormalities in cocaine abusers: Demonstration by SPECT perfusion brain scintigraphy. Radiology 176:821-824.